|
|
|
Volumn 10, Issue 2, 2009, Pages 91-96
|
|
The JUPITER trial: How will it change clinical practice?
|
|
Author keywords
Coronary heart disease; High sensitivity C reactive protein; JUPITER trial; LDL C; Rosuvastatin
|
|
Indexed keywords
C REACTIVE PROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
ROSUVASTATIN;
BIOLOGICAL MARKER;
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
SULFONAMIDE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DIABETES MELLITUS;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
METABOLIC SYNDROME X;
OBESITY;
PREVALENCE;
SHORT SURVEY;
STROKE;
UNSTABLE ANGINA PECTORIS;
BLOOD;
CARDIOVASCULAR DISEASE;
FEMALE;
MALE;
MULTICENTER STUDY;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PREDICTION AND FORECASTING;
PRIMARY PREVENTION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
TREATMENT OUTCOME;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
CHOLESTEROL, LDL;
FEMALE;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MULTICENTER STUDIES AS TOPIC;
PATIENT SELECTION;
PRACTICE GUIDELINES AS TOPIC;
PREDICTIVE VALUE OF TESTS;
PRIMARY PREVENTION;
PYRIMIDINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
RISK FACTORS;
SULFONAMIDES;
TREATMENT OUTCOME;
|
|
EID: 69249231148
PISSN: 15306550
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (9)
|
|
References (10)
|
